I-Mab Biopharma
IMAB
#9469
Rank
โ‚น4.73 B
Marketcap
โ‚น58.13
Share price
-6.87%
Change (1 day)
-61.87%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น1.26 Billion

According to I-Mab Biopharma's latest financial reports the company's total liabilities are โ‚น1.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น1.48 B-26.54%
2022-12-31โ‚น2.02 B6.02%
2021-12-31โ‚น1.90 B57.39%
2020-12-31โ‚น1.21 B-77.96%
2019-12-31โ‚น5.50 B11.79%
2018-12-31โ‚น4.92 B147.15%
2017-12-31โ‚น1.99 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น1.03 B-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น71.35 B 5,540.68%๐Ÿ‡บ๐Ÿ‡ธ USA